SG140505A1 - Diagnostic biomolecule(s) - Google Patents

Diagnostic biomolecule(s)

Info

Publication number
SG140505A1
SG140505A1 SG200605961-2A SG2006059612A SG140505A1 SG 140505 A1 SG140505 A1 SG 140505A1 SG 2006059612 A SG2006059612 A SG 2006059612A SG 140505 A1 SG140505 A1 SG 140505A1
Authority
SG
Singapore
Prior art keywords
biomolecule
diagnostic
diagnostic biomolecule
quantitating
quantification
Prior art date
Application number
SG200605961-2A
Other languages
English (en)
Inventor
Mahesh Arjandas Choolani
Khalil Razvi B M Jabarull Khan
Loganath Annamalai
Arijit Biswas
Zhao Changqing
Original Assignee
Univ Singapore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Singapore filed Critical Univ Singapore
Priority to SG200605961-2A priority Critical patent/SG140505A1/en
Priority to CN200780040599XA priority patent/CN101589308B/zh
Priority to US12/440,004 priority patent/US8551712B2/en
Priority to DE602007011476T priority patent/DE602007011476D1/de
Priority to PCT/SG2007/000264 priority patent/WO2008030186A1/fr
Priority to ES07794274T priority patent/ES2362121T3/es
Priority to AU2007293693A priority patent/AU2007293693C1/en
Priority to EP07794274A priority patent/EP2074427B1/fr
Priority to AT07794274T priority patent/ATE492815T1/de
Publication of SG140505A1 publication Critical patent/SG140505A1/en
Priority to MYPI20090894A priority patent/MY145455A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57449—Specifically defined cancers of ovaries
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
SG200605961-2A 2006-09-05 2006-09-05 Diagnostic biomolecule(s) SG140505A1 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
SG200605961-2A SG140505A1 (en) 2006-09-05 2006-09-05 Diagnostic biomolecule(s)
CN200780040599XA CN101589308B (zh) 2006-09-05 2007-08-20 诊断生物分子
US12/440,004 US8551712B2 (en) 2006-09-05 2007-08-20 Diagnostic biomolecule(s)
DE602007011476T DE602007011476D1 (de) 2006-09-05 2007-08-20 Diagnostik-biomolekül(e)
PCT/SG2007/000264 WO2008030186A1 (fr) 2006-09-05 2007-08-20 Biomolécules diagnostiques
ES07794274T ES2362121T3 (es) 2006-09-05 2007-08-20 Biomolécula(s) de diagnóstico.
AU2007293693A AU2007293693C1 (en) 2006-09-05 2007-08-20 Diagnostic biomolecule(s)
EP07794274A EP2074427B1 (fr) 2006-09-05 2007-08-20 Biomolecules diagnostiques
AT07794274T ATE492815T1 (de) 2006-09-05 2007-08-20 Diagnostik-biomolekül(e)
MYPI20090894A MY145455A (en) 2006-09-05 2009-03-05 Diagnostic biomolecule(s)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SG200605961-2A SG140505A1 (en) 2006-09-05 2006-09-05 Diagnostic biomolecule(s)

Publications (1)

Publication Number Publication Date
SG140505A1 true SG140505A1 (en) 2008-03-28

Family

ID=39157516

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200605961-2A SG140505A1 (en) 2006-09-05 2006-09-05 Diagnostic biomolecule(s)

Country Status (10)

Country Link
US (1) US8551712B2 (fr)
EP (1) EP2074427B1 (fr)
CN (1) CN101589308B (fr)
AT (1) ATE492815T1 (fr)
AU (1) AU2007293693C1 (fr)
DE (1) DE602007011476D1 (fr)
ES (1) ES2362121T3 (fr)
MY (1) MY145455A (fr)
SG (1) SG140505A1 (fr)
WO (1) WO2008030186A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201021509D0 (en) * 2010-12-20 2011-02-02 Reactivlab Ltd Assay method
US9476095B2 (en) 2011-04-15 2016-10-25 The Johns Hopkins University Safe sequencing system
CN102959398B (zh) * 2011-06-29 2015-06-10 培材大学校产学协力团 含有以HpαR为有效成份的肺癌诊断用标记
EP3447495B2 (fr) * 2012-10-29 2024-03-13 The Johns Hopkins University Test de papanicolaou pour cancers de l'endomètre et de l'ovaire
WO2015082706A1 (fr) * 2013-12-05 2015-06-11 Universität Leipzig Procédé et dispositif de diagnostic non invasif de diabète sucré de type ii
WO2017027653A1 (fr) 2015-08-11 2017-02-16 The Johns Hopkins University Analyse du fluide d'un kyste ovarien
EP3467504A4 (fr) * 2016-05-27 2020-02-12 Fujifilm Wako Pure Chemical Corporation Procédé de détermination d'un cancer gastro-intestinal
TWI709188B (zh) 2018-09-27 2020-11-01 財團法人工業技術研究院 基於機率融合的分類器、分類方法及分類系統

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9723773D0 (en) * 1997-11-12 1998-01-07 Univ Glasgow Haptoglobin assay
US7112408B2 (en) * 2001-06-08 2006-09-26 The Brigham And Women's Hospital, Inc. Detection of ovarian cancer based upon alpha-haptoglobin levels
CA2537955A1 (fr) * 2003-09-05 2005-03-17 Royal Women's Hospital Marqueur pour le diagnostic du cancer de l'ovaire
JP2008547028A (ja) * 2005-06-24 2008-12-25 サイファージェン バイオシステムズ， インコーポレイテッド 卵巣癌用のバイオマーカー

Also Published As

Publication number Publication date
WO2008030186A1 (fr) 2008-03-13
MY145455A (en) 2012-02-15
US20100158916A1 (en) 2010-06-24
AU2007293693C1 (en) 2013-11-14
EP2074427A4 (fr) 2010-01-27
AU2007293693B2 (en) 2013-08-01
CN101589308A (zh) 2009-11-25
EP2074427A1 (fr) 2009-07-01
US8551712B2 (en) 2013-10-08
EP2074427B1 (fr) 2010-12-22
DE602007011476D1 (de) 2011-02-03
ES2362121T3 (es) 2011-06-28
CN101589308B (zh) 2013-11-13
AU2007293693A1 (en) 2008-03-13
ATE492815T1 (de) 2011-01-15
WO2008030186A8 (fr) 2009-07-23

Similar Documents

Publication Publication Date Title
MY145455A (en) Diagnostic biomolecule(s)
DE60300339D1 (de) Verfahren zum Nachweis von Karzinomen in solubilisierten zervikalen Körperproben
MY157955A (en) Detection of a target antigen irrespective of the presence or absence of a corresponding therapeutic antibody
SG169395A1 (en) Detection of cancer by elevated levels of bcl-2
WO2006020579A3 (fr) Procede d'identification rapide de micro-organismes
WO2003043487A3 (fr) Procede d'utilisation d'une proteine non anticorps permettant de detecter et de mesurer un analyte
SG141418A1 (en) Method for the detection of gene transcripts in blood and uses thereof
WO2008134526A3 (fr) Profilage de glycoprotéines du cancer de la vessie
TW200720441A (en) New labelling strategies for the sensitive detection of analytes
GB0510943D0 (en) Improved immunoassay methods
WO2006002243A3 (fr) Procedes de profilage d'oligosaccharides pour la detection du cancer
ATE536553T1 (de) Verfahren zum nachweis grösserer ungünstiger kardiovaskulärer und zerebrovaskulärer ereignisse
WO2010033371A3 (fr) Marqueurs moléculaires pour les carcinomes pulmonaires et colorectaux
GB2445488A (en) System for spore detection
WO2008089072A3 (fr) Méthode d'établissement de profils protéomiques pour le diagnostic et la surveillance d'états pathologiques, le criblage de compositions et la surveillance thérapeutique
MXPA06012232A (es) Uso del patron proteogenomico del plasma para diagnostico, clasificacion, prediccion de respuesta a la terapia y comportamiento clinico, estratificacion de la terapia y monitoreo de enfermedad, en malignidades hematologicas.
ES2364314T8 (es) Detección y predicción de preeclampsia.
HK1149956A1 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
GB2437545B (en) Dextrin-containing reagents for detecting and quantifying proteins
WO2006096697A3 (fr) Procedes pour determiner la bivalence d'agents therapeutiques de proteines et d'anticorps
NZ593392A (en) Biomarker for detecting bladder cancer
WO2011109112A3 (fr) Procédé de détection de la protéine tau et des fragments de tau dans le sérum
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome
WO2001083816A3 (fr) Procedes de detection de tumeurs
ATE534037T1 (de) Verwendung des proteins asc als marker für brustkrebs